Journal «Angiology and Vascular Surgery» • 

2010 • VOLUME 16 • №2

PECULIARITIES OF ANTITHROMBOTIC TREATMENT IN EXACERBATION OF CORONARY HEART DISEASE AND TRANSCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS SUFFERING FROM ATRIAL FIBRILLATION AND TAKING VITAMIN К ANTAGONISTS (LITERATURE REVIEW)

Yavelov I.S.
Federal State Facility «Scientific Research Institute for Physical-and-Chemical Medicine» under the Russian Federal Biomedical Agency,
Moscow, Russia

The review analyses various approaches to management of patients presenting with atrial fibrillation and having to take vitamin К agonists in order to prevent arterial thromboembolic complications in cases they develop exacerbations of their coronary hear disease and/or require transcutaneous coronary interventions. With the problem being insufficiently studied as yet, the majority of therapeutic decisions as to the most efficient and safe methods of administering antithrombotic agents in the clinical situations involved are made based on the results of follow up of the patients, the data regarding peculiarities of the action of therapeutic agents, and common sense. Presented herein are contemporary recommendations on long-term antithrombotic therapy in patients suffering from atrial fibrillation and taking vitamin К antagonists and subjected to coronary stenting.

KEY WORDS: coronary heart disease, atrial fibrillation, transcutaneous coronary intervention, anticoagulant therapy, vitamin К antagonists.

P. 22

« Back

Angiologia.ru - portal for professionals
VLAANT
Lancet
HI-TECHNOLOGY MEDICINE